Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biorestorative Therapies Inc (BRTX)

Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biorestorative Therapies Inc 40 MARCUS DRIVE SUITE 1 MELVILLE NY 11747 USA

www.biorestorative.com Employees: 11 P: 631-760-8100

Sector:

Medical

Description:

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company's core programs consist of Disc/Spine Program and Metabolic Program. Disc/Spine Program consists of cell therapy candidate, brtxDISC(TM) is a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow. Metabolic Program consists of ThermoStem(R), developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. BioRestorative Therapies, Inc. is based in Melville, New York.

Key Statistics

Overview:

Market Capitalization, $K 17,231
Enterprise Value, $K 16,361
Shares Outstanding, K 6,920
Annual Sales, $ 150 K
Annual Net Income, $ -14,420 K
Last Quarter Sales, $ 230 K
Last Quarter Net Income, $ -1,090 K
EBIT, $ -12,090 K
EBITDA, $ -11,920 K
60-Month Beta 62.62
% of Insider Shareholders 25.50%
% of Institutional Shareholders 69.38%
Float, K 5,155
% Float 74.50%
Short Volume Ratio 0.46

Growth:

1-Year Return 60.56%
3-Year Return -36.15%
5-Year Return 24.50%
5-Year Revenue Growth 36.36%
5-Year Earnings Growth 99.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 11/12/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -1.73
EPS Growth vs. Prev Qtr 74.00%
EPS Growth vs. Prev Year 79.69%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4000 on 10/27/21

BRTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -98.49%
Return-on-Assets % -75.23%
Profit Margin % -9,613.33%
Debt/Equity 0.00
Price/Sales 45.60
Price/Cash Flow N/A
Price/Book 1.64
Book Value/Share 1.44
Interest Coverage -27.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar